← FDA DRUG APPROVALS

FDA ANDA · ANDA202384

OMEPRAZOLE

Sponsor: LUPIN

APPLICATION
ANDA202384
TYPE
ANDA
ORIGINAL APPROVAL
2015-08-25
LATEST ACTION
2018-06-07
ROUTE
ORAL
DOSAGE FORM
CAPSULE, DELAYED REL PELLETS
MARKETING STATUS
Discontinued

Products

OMEPRAZOLEDiscontinued
OMEPRAZOLE 40MG · CAPSULE, DELAYED REL PELLETS · ORAL

Approval history

2018-06-07Labeling · Supplement 2 · standardAP
2018-05-31Labeling · Supplement 1 · standardAP
2015-08-25UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →